Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-018047

Chief Medical Officer acquired 76,662 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
White Mark Andrew Chief Medical Officer 2023-04-04 Grant or award +76,662 76,662 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
White Mark Andrew Chief Medical Officer 2023-04-04 Grant or award · Stock Option (Right to Buy) +57,739 57,739 D: show line 2 in the form
Loading xslF345X04/form4.xml…